NOVAREX CoLtd (Korea) Performance
| 194700 Stock | KRW 7,380 90.00 1.23% |
The company secures a Beta (Market Risk) of 0.29, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NOVAREX CoLtd's returns are expected to increase less than the market. However, during the bear market, the loss of holding NOVAREX CoLtd is expected to be smaller as well. At this point, NOVAREX CoLtd has a negative expected return of -0.41%. Please make sure to verify NOVAREX CoLtd's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if NOVAREX CoLtd performance from the past will be repeated at some future point.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days NOVAREX CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -34.1 B |
NOVAREX |
NOVAREX CoLtd Relative Risk vs. Return Landscape
If you would invest 966,000 in NOVAREX CoLtd on September 14, 2024 and sell it today you would lose (237,000) from holding NOVAREX CoLtd or give up 24.53% of portfolio value over 90 days. NOVAREX CoLtd is generating negative expected returns and assumes 3.5588% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than NOVAREX, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
NOVAREX CoLtd Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NOVAREX CoLtd's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NOVAREX CoLtd, and traders can use it to determine the average amount a NOVAREX CoLtd's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.115
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 194700 |
Estimated Market Risk
| 3.56 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.41 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NOVAREX CoLtd is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NOVAREX CoLtd by adding NOVAREX CoLtd to a well-diversified portfolio.
NOVAREX CoLtd Fundamentals Growth
NOVAREX Stock prices reflect investors' perceptions of the future prospects and financial health of NOVAREX CoLtd, and NOVAREX CoLtd fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NOVAREX Stock performance.
| Return On Equity | 16.33 | |||
| Return On Asset | 0.0927 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 406.97 B | |||
| Shares Outstanding | 7.95 M | |||
| Price To Sales | 1.13 X | |||
| Revenue | 278.79 B | |||
| EBITDA | 33.46 B | |||
| Cash And Equivalents | 19.17 B | |||
| Total Debt | 22.58 B | |||
| Debt To Equity | 0.45 % | |||
| Cash Flow From Operations | 24.13 B | |||
| Total Asset | 254.63 B | |||
About NOVAREX CoLtd Performance
By analyzing NOVAREX CoLtd's fundamental ratios, stakeholders can gain valuable insights into NOVAREX CoLtd's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NOVAREX CoLtd has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NOVAREX CoLtd has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
NOVAREX Co., Ltd. develops and produces health functional foods and raw materials in South Korea and internationally. NOVAREX Co., Ltd. was founded in 2008 and is headquartered in Cheongju, South Korea. NOVAREX is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about NOVAREX CoLtd performance evaluation
Checking the ongoing alerts about NOVAREX CoLtd for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NOVAREX CoLtd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NOVAREX CoLtd generated a negative expected return over the last 90 days | |
| NOVAREX CoLtd has high historical volatility and very poor performance | |
| About 39.0% of the company shares are owned by insiders or employees |
- Analyzing NOVAREX CoLtd's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NOVAREX CoLtd's stock is overvalued or undervalued compared to its peers.
- Examining NOVAREX CoLtd's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NOVAREX CoLtd's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NOVAREX CoLtd's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NOVAREX CoLtd's stock. These opinions can provide insight into NOVAREX CoLtd's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NOVAREX Stock analysis
When running NOVAREX CoLtd's price analysis, check to measure NOVAREX CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOVAREX CoLtd is operating at the current time. Most of NOVAREX CoLtd's value examination focuses on studying past and present price action to predict the probability of NOVAREX CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOVAREX CoLtd's price. Additionally, you may evaluate how the addition of NOVAREX CoLtd to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |